The global radiation oncology market size reached US$ 7.5 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 11.7 Billion by 2028, exhibiting a growth rate (CAGR) of 7.39% during 2023-2028.
Radiation oncology, also known as radiotherapy, is a cancer treatment that relies on high doses of radiation to kill cancer cells and shrink tumors. It is considered a localized treatment as it affects only the part of the body being treated and damages cancer cells without harming healthy cells. It can be delivered via machines called linear accelerators or through radioactive sources placed inside the patient on a temporary or permanent basis.
Radiation Oncology Market Trends:
The increasing risk of developing cancer on account of tobacco and alcohol consumption, unhealthy diet and physical inactivity among individuals represents one of the key factors bolstering the growth of the market. Besides this, there is a rise in the adoption of radio oncology, which includes external beam radiation therapy, to treat breast, colorectal, esophageal, head, neck, lung, and prostate cancer. It also comprises radioactive iodine therapy (I-131), which can cure a few thyroid cancers, and targeted radionuclide therapy that helps treat advanced prostate cancer or gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Moreover, palliative radiation aids in relieving difficulties like pain, trouble swallowing or breathing, or bowel blockages caused by advanced cancer. This, coupled with the rapid expansion of cancer research centers around the world, is positively influencing the market. Furthermore, key players are focusing on motion tracking, real-time imaging and advancements from 2D to 3D conformal radiotherapy. They are also integrating artificial intelligence (AI) to improve the accuracy, precision, efficiency, and overall effectiveness of radiation oncology. This, in confluence with the increasing investments in research and development (R&D) activities by governments of numerous countries, is projected to fuel the growth of the market in the coming years.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global radiation oncology market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, technology, application and end user.
Breakup by Type:
- External Beam Radiation Therapy
- Linear Accelerators
- Compact Advanced Radiotherapy Systems
- Proton Therapy
- Internal Beam Radiation Therapy
- Systemic Beam Radiation Therapy
Breakup by Technology:
- Image-Guided Radiotherapy (IGRT)
- Intensity Modulated Radiotherapy (IMRT)
- Stereotactic Technology
- Proton Beam Therapy
- 3D Conformal Radiotherapy (3D CRT)
- Volumetric Modulated Arc Therapy (VMAT)
Breakup by Application:
- Prostate Cancer
- Breast Cancer
- Lung Cancer
- Head and Neck Cancer
- Colorectal Cancer
- Gynecological Cancer
- Cervical Cancer
- Penile Cancer
Breakup by End User:
- Cancer Research Institutes
- Ambulatory and Radiotherapy Centers
Breakup by Region:
- North America
- South Korea
- United Kingdom
- Latin America
- Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Accuray Incorporated, Becton Dickinson and Company, Canon Inc., Elekta, Hitachi Ltd., Icad Inc., Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion (Canada) Inc. (Sotera Health), P-Cure Ltd., Varian Medical Systems Inc. (Siemens Healthineers AG) and ViewRay.
|Base Year of the Analysis
||Type, Technology, Application, End User, Region
|| Asia Pacific, Europe, North America, Latin America, Middle East and Africa
||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
||Accuray Incorporated, Becton Dickinson and Company, Canon Inc., Elekta, Hitachi Ltd., Icad Inc., Ion Beam Applications, Isoray Inc., Mevion Medical Systems Inc., Nordion (Canada) Inc. (Sotera Health), P-Cure Ltd., Varian Medical Systems Inc. (Siemens Healthineers AG) and ViewRay.
||10% Free Customization
|Report Price and Purchase Option
||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support
||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report:
- How has the global radiation oncology market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global radiation oncology market?
- What are the key regional markets?
- What is the breakup of the market based on the type?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global radiation oncology market and who are the key players?
- What is the degree of competition in the industry?